157 related articles for article (PubMed ID: 38301904)
1. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
Al Farii H; McChesney G; Patel SS; Rhines LD; Lewis VO; Bird JE
Spine J; 2024 Jun; 24(6):1056-1064. PubMed ID: 38301904
[TBL] [Abstract][Full Text] [Related]
2. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
Yonezawa N; Murakami H; Kato S; Takeuchi A; Tsuchiya H
Eur Spine J; 2017 May; 26(Suppl 1):236-242. PubMed ID: 28396950
[TBL] [Abstract][Full Text] [Related]
3. Recurrent giant cell tumour of the thoracic spine managed by total en bloc spondylectomy and denosumab therapy: a case report.
Duan PG; Sheng YH; Deng CH; Tang BY; Yao HQ
BMC Musculoskelet Disord; 2020 Feb; 21(1):105. PubMed ID: 32061254
[TBL] [Abstract][Full Text] [Related]
4. Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases.
Dubory A; Missenard G; Domont J; Court C
Spine (Phila Pa 1976); 2016 Jun; 41(11):E654-E660. PubMed ID: 27244112
[TBL] [Abstract][Full Text] [Related]
5. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
Mattei TA; Ramos E; Rehman AA; Shaw A; Patel SR; Mendel E
Spine J; 2014 Jul; 14(7):e15-21. PubMed ID: 24534393
[TBL] [Abstract][Full Text] [Related]
6. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
[TBL] [Abstract][Full Text] [Related]
7. Morphological Transformation of Giant-Cell Tumor of Bone After Treatment with Denosumab: A Case Report.
Zhang Y; Ilaslan H; Krishnaney AA; Bauer TW
JBJS Case Connect; 2016; 6(3):e74. PubMed ID: 29252651
[TBL] [Abstract][Full Text] [Related]
8. Giant cell tumors of the spine: has denosumab changed the treatment paradigm?
Goldschlager T; Dea N; Boyd M; Reynolds J; Patel S; Rhines LD; Mendel E; Pacheco M; Ramos E; Mattei TA; Fisher CG
J Neurosurg Spine; 2015 May; 22(5):526-33. PubMed ID: 25700239
[TBL] [Abstract][Full Text] [Related]
9. Can Denosumab cure giant cell tumors of the spine? A case report and literature review.
Xará-Leite F; Coutinho L; Fleming C; Magalhães M; Oliveira V; Rodrigues-Pinto R; Cardoso P
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):19-23. PubMed ID: 31529151
[TBL] [Abstract][Full Text] [Related]
10. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
[TBL] [Abstract][Full Text] [Related]
11. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
Agarwal MG; Gundavda MK; Gupta R; Reddy R
Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
[TBL] [Abstract][Full Text] [Related]
12. Giant cell tumor of the sacrum and spine: series of 23 cases and a review of the literature.
Martin C; McCarthy EF
Iowa Orthop J; 2010; 30():69-75. PubMed ID: 21045974
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
Deveci MA; Paydaş S; Gönlüşen G; Özkan C; Biçer ÖS; Tekin M
Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report.
Tang Q; Lu J; Zhu X; Song G; Wu H; Xu H; Wang A; Wang J
Eur Spine J; 2023 Dec; 32(12):4297-4305. PubMed ID: 37318598
[TBL] [Abstract][Full Text] [Related]
15. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
Zhang RZ; Ma TX; Qi DW; Zhao M; Hu T; Zhang GC
Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217
[TBL] [Abstract][Full Text] [Related]
16. Denosumab in the treatment of giant cell tumor of the spine. Preliminary report, review of the literature and protocol proposal.
Boriani S; Cecchinato R; Cuzzocrea F; Bandiera S; Gambarotti M; Gasbarrini A
Eur Spine J; 2020 Feb; 29(2):257-271. PubMed ID: 31098716
[TBL] [Abstract][Full Text] [Related]
17. Morphologic Changes After Denosumab Therapy in Patients with Giant Cell Tumor of the Spine: Report of Four Cases and a Review of the Literature.
Yonezawa N; Murakami H; Demura S; Kato S; Yoshioka K; Takeuchi A; Shinmura K; Yokogawa N; Shimizu T; Oku N; Kitagawa R; Handa M; Tsuchiya H
World Neurosurg; 2019 Jul; 127():38-46. PubMed ID: 30926552
[TBL] [Abstract][Full Text] [Related]
18. Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
Hindiskere S; Errani C; Doddarangappa S; Ramaswamy V; Rai M; Chinder PS
Clin Orthop Relat Res; 2020 Nov; 478(11):2522-2533. PubMed ID: 32401001
[TBL] [Abstract][Full Text] [Related]
19. Denosumab salvage therapy in an 11-year-old boy with locally recurrent unresectable giant cell tumor of the lumbar spine after surgery.
Luo Y; Xiu P; Chen H; Zeng J; Song Y; Li T
Neurochirurgie; 2023 May; 69(3):101427. PubMed ID: 36828057
[TBL] [Abstract][Full Text] [Related]
20. Role of denosumab before resection and reconstruction in giant cell tumors of bone: a single-centered retrospective cohort study.
Sahito B; Ali SME; Kumar D; Kumar J; Hussain N; Lakho T
Eur J Orthop Surg Traumatol; 2022 Apr; 32(3):567-574. PubMed ID: 34050817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
